good work by gsk - but deep down i feel we'd be better of with roche for lani - they seem to have a mean machine when it comes to pushing their blockbusters and they also have deeper pockets than gsk for any upfront payment and thirdly they are already used to paying big royalties a la tamiflu.
new uk deal for relenza, page-7
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)